Hydrogenics (NASDAQ:HYGS) Issues Earnings Results

Share on StockTwits

Hydrogenics (NASDAQ:HYGS) (TSE:HYG) announced its earnings results on Monday. The energy company reported ($0.25) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.13), Morningstar.com reports. The firm had revenue of $10.46 million during the quarter, compared to the consensus estimate of $10.50 million. Hydrogenics had a negative return on equity of 78.93% and a negative net margin of 41.47%.

Shares of HYGS stock opened at $14.93 on Wednesday. Hydrogenics has a fifty-two week low of $3.80 and a fifty-two week high of $16.50. The stock has a market capitalization of $283.94 million, a price-to-earnings ratio of -17.36 and a beta of 0.63. The business’s 50-day simple moving average is $14.89.

A number of equities research analysts have recently weighed in on the company. Craig Hallum lowered Hydrogenics from a “buy” rating to a “hold” rating in a research note on Friday, June 28th. HC Wainwright lowered Hydrogenics from a “buy” rating to a “neutral” rating in a research note on Friday, June 28th. ValuEngine upgraded Hydrogenics from a “buy” rating to a “strong-buy” rating in a research note on Thursday, May 30th. Roth Capital boosted their price target on Hydrogenics from $8.50 to $15.00 and gave the stock a “neutral” rating in a research note on Monday, July 1st. Finally, Canaccord Genuity lowered Hydrogenics from a “buy” rating to a “hold” rating in a research note on Friday, June 28th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $10.92.

Several hedge funds have recently modified their holdings of HYGS. Gabelli Funds LLC purchased a new stake in shares of Hydrogenics during the second quarter worth about $2,180,000. SG Americas Securities LLC purchased a new stake in shares of Hydrogenics during the second quarter worth about $764,000. Renaissance Technologies LLC grew its stake in shares of Hydrogenics by 223.9% during the second quarter. Renaissance Technologies LLC now owns 54,250 shares of the energy company’s stock worth $806,000 after acquiring an additional 37,500 shares during the last quarter. TSP Capital Management Group LLC grew its stake in shares of Hydrogenics by 2.3% during the second quarter. TSP Capital Management Group LLC now owns 1,279,653 shares of the energy company’s stock worth $19,003,000 after acquiring an additional 29,050 shares during the last quarter. Finally, Cetera Advisor Networks LLC purchased a new stake in shares of Hydrogenics during the second quarter worth about $318,000. Institutional investors and hedge funds own 11.09% of the company’s stock.

Hydrogenics Company Profile

Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane (PEM) technology. It operates through two segments, OnSite Generation and Power Systems.

Featured Story: Terms to Better Understand Call Options

Earnings History for Hydrogenics (NASDAQ:HYGS)

Receive News & Ratings for Hydrogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Swiss National Bank Raises Stock Position in bluebird bio Inc
Swiss National Bank Raises Stock Position in bluebird bio Inc
Swiss National Bank Decreases Stock Position in Chemours Co
Swiss National Bank Decreases Stock Position in Chemours Co
Swiss National Bank Has $13.15 Million Position in Coty Inc
Swiss National Bank Has $13.15 Million Position in Coty Inc
Swiss National Bank Acquires 5,200 Shares of Servicemaster Global Holdings Inc
Swiss National Bank Acquires 5,200 Shares of Servicemaster Global Holdings Inc
Swiss National Bank Purchases 700 Shares of Nordson Co.
Swiss National Bank Purchases 700 Shares of Nordson Co.
Sigma Planning Corp Invests $201,000 in Mirati Therapeutics Inc
Sigma Planning Corp Invests $201,000 in Mirati Therapeutics Inc


© 2006-2019 Ticker Report